Group One Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2202 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2116 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2175 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1845 |
|
|
2024
Q2 | – | Sell |
-46,044
| Closed | -$234K | – | 1870 |
|
|
2024
Q1 | $234K | Buy |
46,044
+14,616
| +47% | +$74.2K | ﹤0.01% | 621 |
|
|
2023
Q4 | $188K | Buy |
31,428
+19,537
| +164% | +$117K | ﹤0.01% | 758 |
|
|
2023
Q3 | $84.2K | Buy |
+11,891
| New | +$84.2K | ﹤0.01% | 963 |
|
|
2023
Q2 | – | Sell |
-100,976
| Closed | -$842K | – | 1917 |
|
|
2023
Q1 | $842K | Sell |
100,976
-61,572
| -38% | -$514K | ﹤0.01% | 342 |
|
|
2022
Q4 | $1.87M | Buy |
162,548
+91,174
| +128% | +$1.05M | ﹤0.01% | 242 |
|
|
2022
Q3 | $899K | Sell |
71,374
-75,072
| -51% | -$946K | ﹤0.01% | 425 |
|
|
2022
Q2 | $1.55M | Buy |
+146,446
| New | +$1.55M | ﹤0.01% | 339 |
|
|
2022
Q1 | – | Sell |
-138,644
| Closed | -$1.92M | – | 2130 |
|
|
2021
Q4 | $1.92M | Buy |
138,644
+21,459
| +18% | +$297K | ﹤0.01% | 487 |
|
|
2021
Q3 | $1.68M | Buy |
+117,185
| New | +$1.68M | ﹤0.01% | 478 |
|
|
2021
Q2 | – | Sell |
-123,699
| Closed | -$1.26M | – | 2082 |
|
|
2021
Q1 | $1.26M | Sell |
123,699
-92,326
| -43% | -$939K | ﹤0.01% | 489 |
|
|
2020
Q4 | $1.61M | Buy |
216,025
+79,048
| +58% | +$589K | ﹤0.01% | 363 |
|
|
2020
Q3 | $471K | Buy |
136,977
+54,452
| +66% | +$187K | ﹤0.01% | 561 |
|
|
2020
Q2 | $393K | Buy |
+82,525
| New | +$393K | ﹤0.01% | 492 |
|
|
2020
Q1 | – | Sell |
-5,558
| Closed | -$19K | – | 1441 |
|
|
2019
Q4 | $19K | Buy |
5,558
+2,473
| +80% | +$8.45K | ﹤0.01% | 1042 |
|
|
2019
Q3 | $9K | Sell |
3,085
-101,205
| -97% | -$295K | ﹤0.01% | 1112 |
|
|
2019
Q2 | $395K | Buy |
104,290
+101,470
| +3,598% | +$384K | ﹤0.01% | 392 |
|
|
2019
Q1 | $23K | Buy |
+2,820
| New | +$23K | ﹤0.01% | 884 |
|
|
2018
Q4 | – | Sell |
-3,879
| Closed | -$30K | – | 1411 |
|
|
2018
Q3 | $30K | Sell |
3,879
-3,404
| -47% | -$26.3K | ﹤0.01% | 1051 |
|
|
2018
Q2 | $42K | Buy |
7,283
+4,295
| +144% | +$24.8K | ﹤0.01% | 943 |
|
|
2018
Q1 | $14K | Buy |
2,988
+1,594
| +114% | +$7.47K | ﹤0.01% | 1067 |
|
|
2017
Q4 | $7K | Sell |
1,394
-45,973
| -97% | -$231K | ﹤0.01% | 1201 |
|
|
2017
Q3 | $248K | Buy |
+47,367
| New | +$248K | ﹤0.01% | 590 |
|
|
2017
Q2 | – | Sell |
-95,908
| Closed | -$806K | – | 1340 |
|
|
2017
Q1 | $806K | Buy |
95,908
+14,732
| +18% | +$124K | 0.01% | 276 |
|
|
2016
Q4 | $514K | Buy |
81,176
+77,460
| +2,084% | +$490K | 0.01% | 358 |
|
|
2016
Q3 | $16K | Sell |
3,716
-9,181
| -71% | -$39.5K | ﹤0.01% | 941 |
|
|
2016
Q2 | $37K | Buy |
12,897
+6,719
| +109% | +$19.3K | ﹤0.01% | 784 |
|
|
2016
Q1 | $17K | Buy |
+6,178
| New | +$17K | ﹤0.01% | 920 |
|
|
2015
Q4 | – | Sell |
-2,770
| Closed | -$32K | – | 1385 |
|
|
2015
Q3 | $32K | Buy |
+2,770
| New | +$32K | ﹤0.01% | 1020 |
|
|
2015
Q2 | – | Sell |
-9,735
| Closed | -$88K | – | 1393 |
|
|
2015
Q1 | $88K | Buy |
+9,735
| New | +$88K | ﹤0.01% | 707 |
|
|
2014
Q4 | – | Sell |
-15,064
| Closed | -$147K | – | 1467 |
|
|
2014
Q3 | $147K | Buy |
+15,064
| New | +$147K | ﹤0.01% | 624 |
|
|
2014
Q2 | – | Sell |
-6,599
| Closed | -$70K | – | 1513 |
|
|
2014
Q1 | $70K | Sell |
6,599
-64,526
| -91% | -$684K | ﹤0.01% | 826 |
|
|
2013
Q4 | $541K | Buy |
71,125
+36,320
| +104% | +$276K | 0.01% | 343 |
|
|
2013
Q3 | $253K | Buy |
34,805
+19,686
| +130% | +$143K | ﹤0.01% | 452 |
|
|
2013
Q2 | $23K | Buy |
+15,119
| New | +$23K | ﹤0.01% | 1044 |
|